In addition, correlations between CHSY3 expression and GC patient clinicopathological characteristics were examined, revealing higher levels of CHSY3 expression to be correlated with depth of invasion, advanced TNM stage, and lymph node metastasis (Table 1). The gene discussed is CHSY3; the disease is gastric cancer.